Article
The multidrug-resistance protein 4 polymorphism is a new factor accounting for thiopurine sensitivity in Japanese patients with inflammatory bowel disease.
Journal of gastroenterology - 1 Oct 2010
Ban Hiromistu, Andoh Akira, Imaeda Hirotsugu, Kobori Ayako, Bamba Shigeki, Tsujikawa Tomoyuki, Sasaki Masaya, Saito Yasuharu, Fujiyama Yoshihide
Abstract excerpt
BACKGROUND: Multidrug resistance protein 4 (MRP4) functions as an efflux pump of nucleoside monophosphate analogs, such as 6-mercaptopurine (6-MP) and 6-thioguanine nucleotide (6-TGN). A single-nucleotide polymorphism in human MRP4 (rs3765534) dramatically reduces MRP4 function and results in the intracellular accumulation of 6-TGN. In this study, we investigated the association between MRP4 G2269A polymorphism...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
